Changes in Myokines in Youths With Severe Obesity Following Roux-en-Y Gastric Bypass Surgery

Comparison of roux-en-y gastric bypass techniques with and without distal gastric plication in patients with morbid obesity

Kidney stone risk following Roux-en-Y gastric bypass surgery

Since the first report in 2005, Roux-en-Y gastric bypass (RYGB) surgery has been linked to a variety of metabolic changes that alter kidney stone risk. The studies with the highest level of evidence, performed in non-stone forming patients before and after RYGB, cite a number of kidney stone risk factors, including a 25% increase in urinary oxalate, a 30% decrease in urinary citrate, and reduct...

Iron nutriture following roux-en-y gastric bypass surgery

Changes in B-Type Natriuretic Peptide and BMI Following Roux-en-Y Gastric Bypass Surgery

Obesity and attendant complications including type 2 diabetes mellitus, hypertension (HTN), and heart disease are worldwide epidemics with incompletely understood associations. Mechanisms underlying the association of HTN and obesity include upregulation of the renin-angiotensin-aldosterone system, sympathetic nervous system, insulin resistance, and adipose tissue activity, but a paradoxically ...

Pregnancy following gastric bypass surgery (Roux-en-Y) for morbid obesity

Morbidly obese women are at increased risk of obstetric complications and poor neonatal outcomes. Gastric bypass surgery is being performed with increased frequency in reproductive-aged women to treat morbid obesity. Both maternal and fetal complications have been reported in women who underwent gastric bypass surgery. Current recommendations advise delaying pregnancy for at least 1 year follow...